The Cooper Companies Inc (NAS:COO)
$ 104.71 -0.52 (-0.49%) Market Cap: 20.85 Bil Enterprise Value: 23.48 Bil PE Ratio: 58.32 PB Ratio: 2.63 GF Score: 95/100

Cooper Companies Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / 11:00PM GMT
Release Date Price: $92.83 (-0.60%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Good afternoon, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. Very happy to introduce our next session Al White, the CEO of CooperCompanies. Al will do a 20-minute presentation, then we'll do some Q&A.

Albert G. White
CooperCompanies - President, CEO & Non-Independent Director

Fantastic. Thank you, Robbie. We'll jump right into it here. Our first slide, for those of you who do not know us, CooperCompanies, a leading global medical device company. We're a leader in the vision space and in the women's health, fertility, OB-GYN space. Within the vision space, we operate under CooperVision, which is about 2/3 of our revenues in the contact lens business. So we'll spend a lot of time here as we go through this presentation on the contact lens industry.

We've been a member of the S&P 500 since 2016 and recently moved to NASDAQ and now trade under NASDAQ under COO. A couple of interesting points here, just 50 million plus people benefiting from our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot